Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
13 participants
OBSERVATIONAL
2015-07-31
2016-04-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
The Effect of Womb Recordings on Maturation of Respiratory Control in Preterm Infants
NCT05298748
Intraoral Measurement of Pressure in Preterm Infants
NCT04800198
Assessment of Autonomic Maturation in Neonatal Period and Early Neural Development From a Longitudinal Prospective Cohort
NCT00951860
High Risk Factor, Clinical Feature, and Follow up of Neonatal Arrhythmia
NCT04899596
Apgar-Score in Asphyxiated Infants Under Resuscitation
NCT01193751
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
In this single-centre pilot study 15 preterm infants of 32 to 42 weeks gestational age will be included. Transesophageal ECG and EMG signals will be measured using an Edi-gastric tube (Maquet, Getinge Group, Solna Sweden), a CE-certified neonatal gastric tube equipped with electrodes. Due to the proximity of the esophageal electrodes within the gastric tube to the heart and diaphragm, esophageal ECG and EMG signals can be acquired and are probably less susceptible to motion artefacts of the baby than the commonly used skin electrodes. This is well known from measurements in adults. Moreover, motion of esophageal electrodes due to peristalsis, respiration and cardiac motion superimposes the ECG as baseline wander and might be a surrogate for the coordination abilities of preterm infants.
Using these novel esophageal data this study's goal is to obtain objective data representing maturational patterns of breathing, heart rate, and swallowing in preterm infants. Possibly derived coordination patterns might help to guide nurses and clinicians to introduce suck feeds and to develop specific early intervention strategies. Furthermore, if the gastric tube-EMG proves to be accessible in real time, it could potentially replace standard monitoring tools that require the use of skin electrodes in the future. This would not only facilitate nursing and preserve skin integrity but also simplify bonding between the parents and their infants in the NICU.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_ONLY
PROSPECTIVE
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Gestational age of 32 to 42 weeks
* Study start possible in the course of participant's 4th-10th day of life
* Presumed NICU stay ≥ 5 days from study start onwards
* Need for a gastric feeding tube for clinical reasons for ≥ 5 days from study start onwards
Exclusion Criteria
* Circulatory instability (in need of therapy with vasoactive substances)
* Endotracheal ventilation
* Infant in extremis
4 Days
10 Days
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Bern University of Applied Sciences
OTHER
Sven Schulzke
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Sven Schulzke
Director, Department of Neonatology
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Sven Schulzke, Prof
Role: PRINCIPAL_INVESTIGATOR
University Children's Hospital Basel
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
University Children's Hospital Basel
Basel, Canton of Basel-City, Switzerland
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2015136
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.